CD4+ T cells orchestrate both amplification and deletion of CD8+ T cells

Critical Reviews in Immunology

Volumn 18, Issue 6, 1998, Pages 569-594

  Frasca, Loredana ^a   Piazza, Cinzia ^a   Piccolella, Enza ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Activation; Anergy; Apoptosis; Fas FasL interaction; Tolerance

Indexed keywords

ARTICLE; GENE DELETION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031787896     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v18.i6.50     Document Type: Article

References (221)

1. Romagnani, S., The Th1/Th2 paradigm, Immunol. Today, 18, 263-266, 1997.
2. Romagnani, S., Th1 and Th2 in human diseases, Clin. Immunol. Immunopathol., 80, 225-235, 1996.
3. Mosmann, T. R., Li, L., and Sad, Subash, Functions of CDS T-cell subsets secreting different cytokine patterns, Semin. Immunol., 9, 87-92, 1997.
4. Guerder, S. and Matzinger, P., A fail-safe mechanism for maintaining self-tolerance, J. Exp. Med., 176, 553-564, 1992.
5. Keene, J.-A. and Forman, J., Helper activity is required for the in vivo generation of cytotoxic T lymphocytes, J. Exp. Med., 155, 768-782, 1982.
6. Cassell, D. and Forman, J., Linked recognition of helper and cytotoxic antigen determinants for the generation of cytotoxic T lymphocytes, Ann. NY Acad. Sci., 532, 51-60, 1988.
7. Husmann, L. A. and Bevan, M. J., Cooperation between helper T cells and cytotoxic T lymphocytes precursors, Ann. NY Acad. Sci., 532, 158-169, 1988.
8. Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N., and Morse, H. C., III, Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells, Nature, 328, 77-79, 1987.
9. + T cells, Immunol. Cell. Biol., 67, 413-420, 1989.
10. + cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection, J. Immunol., 146, 1955-1963, 1991.
11. + cells but markedly decreased helper cell activity in mice lacking CD4, Nature, 353, 180-184, 1991.
12. Stuhler, G. and Schlossman, S. F., Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T-cell subsets, Proc. Natl. Acad. Sci. U.S.A., 94, 622-627, 1997.
13. + CTL in vivo with peptide vaccine constructs, J. immunol., 152, 549-557, 1994.
14. Takahashi, H., Germain, R. N., Moss, B., and Berzofsky, J. A., An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself, J. Exp. Med., 171, 571-576, 1990.
15. + T cells, J. Exp. Med., 186, 239-245, 1997.
16. + T-cell help, J. Exp. Med., 186, 65-70, 1997.
17. Carbone, F. R. and Bevan, M. J., Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo, J. Exp. Med., 171, 377-387, 1990.
18. Nuchtern, J. G., Biddison, W. E., and Klausner, R. D., Class II MHC molecules can use the endogenous pathway of antigen presentation, Nature, 343, 74-76, 1990.
19. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F., and Kosaka, H., Constitutive class I-restricted exogenous presentation of self antigens in vivo, J. Exp. Med., 184, 923-930, 1996.
20. Day, P. M., Yedwell, J. W., Porgador, A., Germain, R. N., and Bennink, J. R., Direct delivery of exogenus MHC class I molecule-binding oligopeptides to the eudoplasmic reticulum of viable cells, Proc. Natl. Acad. Sci. U.S.A., 94, 8064-8069, 1997.
21. Oxenius, A., Bachmann, M. F., Mathis, D., Benoist, C., Zinkernagel, R. M., and Hengartner, H., Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection, J. Immunol., 158, 5717-5726, 1997.
22. + T cells, J. Exp. Med., 185, 2133-2141, 1997.
23. Svensson, M., Stockinger, B., and Wick, M. J., Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells, J, Immunol., 158, 4229-4236, 1997.
24. + human lymphocytes are activated and proliferate in response to Cryptococcus neoformans, Immunology, 92, 194-200, 1997.
25. Hoy, J. F., Lewis, D. E., and Miller, G. P., Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro responses to C. Neoformans, J. Infect. Dis., 158, 1071-1078, 1988.
26. Jenning, S. R., Bonneau, R. H., Smith, P. M., Wolcott, R. M., and Chervenak, R., CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CDS-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/mice, Cell. Immunol., 133, 234-252, 1991.
27. Ferrari, C., Mondelli, M. U., Penna, A., Fiaccadori, F., and Chisari, F. V., Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T-cell lines, J. Immunol., 139, 539-344, 1987.
28. Ferrari, C., Penna, A., Bertoletti, A., Valli, A., Antoni, A. D., Giuberti, T., Cavalli, A., Petit, M. A., and Fiaccadori, F., Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection, J. Immunol., 145, 3442-3449, 1990.
29. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C, J. Exp. Med., 178, 17-25, 1993.
30. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M. G., Houghton, M., Fiaccadori, F., and Ferrari, C., Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the antiviral cell-mediated immune response, J. Clin. Invest., 98, 706-714, 1996.
31. Abrignani, S., Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view, Springer Semin. Immunopathol., 19, 47-55, 1997.
32. Lechler, R. I. and Batchelor, J. R., Restoration of immunogenicity to passenger cell-depleted kidney allografts by addition of donor strain dendritic cells, J. Exp. Med., 155, 31-41, 1982.
33. Bal, V., McIndoe, A., Denton, G., Hudson, D., Lombardi, G., Lamb, J., and Lechler, R. I., Antigen presentation by keratinocytes induces tolerance in human T cells, Eur. J. Immunol., 20, 1893-1897, 1990.
34. Warrens, A. N., Zhang, J. Y., Sidhu, S., Watt, D. J., Lombardi, G., Sewry, C. A., and Lechler, R. I., Myoblasts fail to stimulate T cells but induce tolerance, Int. Immunol., 6, 847-853, 1994.
35. Marelli-Berg, F. M., Hargreaves, R., Carmicheal, P., Dorling, A., Lombardi, G., and Lechler, R. I., Major histocompatibility Complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells, J. Med., 183,1603-1612, 1996.
36. Lombardi, G., Arnold, K., Uren, J., Marelli-Berg, F., Hargreaves, R., Imami, N., Weetman, A., and Lechler, R. I., Antigen presentation by interferon-γtreated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells, Eur. J. Immunol., 27, 62-71, 1997.
37. + T cells, J. Immunol., 159, 5853-5861, 1997.
38. Frasca, L., Marelli-Berg, F., Imami, N., Potolicchio, I., Carmichael, P., Lombardi, G., and Lechler, R. I., IFN-γ-treated renal tubular epithelial cells induce allospecific tolerance, Kidney Int., 53, 679-680, 1998.
39. Opelz, G., HLA matching analysis of cyclosporine-treated cadaver kidneys transplanted in 1986, Transplant. Proc., 19, 3557-3558, 1987.
40. Mitchison, N. A. and O'Malley, C., Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response, Eur. J. Immunol., 17, 1579-1583, 1987.
41. Matzinger, P. and Bevan, M. J., Hypotesis: why do so many lymphocytes respond to major histocompatibility antigens?, Cell. Immunol., 29, 1-5, 1977.
42. Bevan, M. J., High determinant density may explain the phenomenon of alloractivity, Immunol., Today, 5, 128-131, 1984.
43. Qin, S., Cobbold, S. P., Tighe, H., Benjamin, R., and Waldmann, H., CD4 monoclonal antibody pairs for immunosuppression and tolerance induction, Eur. J. Imm., 17, 1159-1165, 1987.
44. Cobbold, S. P., Martin, G., and Waldmann, H., The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies, Eur. J. Immunol., 1990; 20, 2747-2755, 1990.
45. Cohen, Z., Cobbold, S. P., Metcalfe, S., and Waldmann, H., Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CDS, Eur. J. Immunol., 2, 805-810, 1992.
46. Mottram, P. L., Purcell, L. J., Pietersz, G. A., and McKenzie, I. F. C., Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model, Transplant. P., 25, 2935-2936, 1993.
47. + T-cell recognition during the induction phase of the response, Eur. J. Immunol., 25, 2643-2649, 1995.
48. + cells are essential for allorejection, J. Exp. Med., 184, 2013-2018, 1996.
49. Chen, B. P. Madrigal, A., and Parham, P., Cytotoxic T-cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule, J. Exp. Med., 172(3), 779-788, 1990.
50. Dalchau, R., Fangmann, J., and Fabre, J. W., Allorecognition of isolated denatured chains of class I and class II MHC molecules, evidence for and an important role for indirect allorecognition in transplantation, Eur. J. Immunol., 22, 669-677, 1992.
51. Fangmann, J., Dalchau, R., and Fabre, J. W., Rejection of skin allografts by indirect allorecognition of donor class I MHC peptides, J. Exp. Med., 175, 1521-1529, 1992.
52. Liu, Z., Sun, Y. K., Xi, Y. P., Harris, P., and Suciu-Foca, N., T-cell recognition of self-human histocompatibility leucocyte antigens (HLA)-DR peptides in the context of syngeneic HLA-DR molecules, J. Exp. Med., 175, 1663-1668, 1992.
53. Auchincloss, H., Jr., Lee, R., Shea, S. Markiwitz, J. S., Grusby, M. J., and Glimcher, L. H., The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II deficient mice, Proc. Natl. Acad. Sci. U.S.A., 90, 3373-3377, 1993.
54. Liu, Z., Sun, Y. K., Xi, Y. P., Maffei, A., Reed, E., Harris, P., and Suciu-Foca, N., Contribution of direct and indirect recognition pathways to T cell alloreactivity, J. Exp. Med., 177, 1643-1650, 1993.
55. Liu, Z., Colovai, A. I., Tugulea, S., Reed, E. F., Fisher, P. E., Mancini, D., Rose, E. A., Cortesini, R., Michler, R. E., and Suciu-Foca, N., Indirect recognition of donor HLA-DR peptides in organ allograft rejection, J. Clin. Invest., 98, 1150-1157, 1996.
56. Liu, Z., Harris, P. E., Colovai, A., Reed, E. F., Maffei, A., and Suciu-Foca, N., Indirect recognition of donor MHC class II antigens in human transplantation, Clin, Immunol. Immunopathol., 78, 228-235, 1996.
57. Frasca, L., Amendola, A., Hornick, P., Brookes, P., Aitchinger, G., Marelli-Berg, F. M., Lechler, R. I., and Lombardi G., The role of donor and recipient antigen presenting cells in priming and maintaining T cells with indirect allospecificity, Transplantation, in press, 1998.
58. Suciu-Foca, N., Reed, E., Marboe, C., Harris, P., Yu, P. X., Sun, Y. K., Ho, E., Rose, E., Reemtsma, K., and King, D. W., The role of anti HLA antibodies in heart transplantation, Transplantation, 51, 716-724, 1991.
59. Lee, R. S., Grusby, M. J., Glimcherr, L. H., Winn, H., and Auchincloss, H., Jr., Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo, J. Exp. Med., 119, 865-872, 1994.
60. Steele, D. J. R., Laufer, T. M., Smiley, S. T., Ando, Y., Grusby, M. J., Glimcher, L. H., and Auchincloss, H., Jr., Two levels of help for B cell alloantibody production, J. Exp. Med., 183, 699-703, 1996.
61. Di Rosa, F. and Matzinger, P., Long-lasting CD8 T-cell memory in the absence of CD4 T cells or B cells, J. Exp. Med., 183, 2153-2163, 1996.
62. + T cells, J. Exp. Med., 184, 863-871, 1996.
63. + cytotoxic Tcell responses during chronic viral infection, J. Virol., 68, 8056-8063, 1994.
64. Fauci, A. S., Multifactorial nature of human immuno-deficiency Virus disease: implications for therapy, Science, 262, 1011-1018, 1993.
65. +T-cell deficient mice, J. Virol., 68, 4700-4704 1994.
66. von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B. A., and Whitton, J. L., CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge, J. Virol., 70, 1072-1079, 1996.
67. + cells after a transient response to antigen, Eur. J. Immunol., 23, 1963-1967, 1993.
68. +Bcl-2 (low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients, Am. J. Pathol., 146(6), 1542-1555, 1995.
69. + T lymphocytes during HIV infections, J. Immunol., 156(6), 2282-2293, 1996.
70. Akbar, A. N., Borthwick, N., Salmon, M., Gombert, W., Bofill, M., Shamsadeen, N., Pilling, D., Pett, S., Grundy, J. E., and Janossy, G., The significance of low Bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T-cell memory, J. Exp. Med., 178(2), 427-438, 1993.
71. Salmon, M., Pilling, D., Borthwick, N. J., Viner, N., Janossy, G., Bacon, P. A., and Akbar, A. N., The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis, Eur. J. Immunol., 24(4), 892-899, 1994.
72. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T-cell stimulatory capacity: T-T help via APC activation, J. Exp. Med., 184, 747-752, 1996.
73. Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R. M., Romani, N., and Schuler, G., Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells, Eur. J. Immunol., 26, 659-668, 1996.
74. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., and Sinigaglia, F., Selective expression of an interleukin-12 receptor component by human T helper I cells, J. Exp. Med., 185, 825-831, 1997.
75. Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., Boyer, J. D., and Weiner, D. B., In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen, J. Immunol., 158, 816-826, 1997.
76. Grohmann, U., Bianchi, R., Ayroldi, E., Belladonna, M. L., Surace, D., Fioretti, M. C., and Puccetti, P., A tumor-associated and self antigen peptide presented by dendritic cells may induce T-cell anergy in vivo, but IL-12 can prevent or revert the anergic state, J. Immunol., 158, 3593-3602, 1997.
77. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes, Transplantation, 60, 1539-1545, 1995.
78. Khoury, S. J., Gallon, L., Chen, W., Betres, D., Russel, M. E., Hancock, W. W., Carpenter, C. B., Sayegh, M. H., and Weiner, H. L., Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T-cell unresponsiveness in vivo, J. Exp. Med., 182, 357-366, 1995.
79. Finkelman, F. D., Lees, A., Bimbaum, R., Cause, W. C., and Morris, S. C., Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion, J. Immunol., 157, 1406-1414, 1996.
80. -) prolong cardiac allograft survival in nonimmunosuppressed recipients, Transplantation, 62, 659-665, 1996.
81. Schoenberger, S. P., Toes, R. E. M., Van der Voort, E. I. H., Offringa, R., and Melief, C. J. M., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions, Nature, 393, 480-483, 1998.
82. Bennett, S. R. M., Carbone, F. R., Karamilis, F., Flavell, R. A., Miller J. F. A. P., and Heath, W. R., Help for cytotoxic-T-cell responses is mediated by CD40 signaling, Nature, 393, 478-480, 1998.
83. Grewal, I. S., Xu, J., and Flavell, R. A., Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand, Nature, 378, 617-620, 1995.
84. Koppi, T. A., Tough-Bement, T., Lewinsohn, D. M., Lynch, D. H., and Alderson, M. R., CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells, Eur. J. Immunol., 27, 3161-3165 1997.
85. + T-helper cell and a T killer cell, Nature, 393, 474-478, 1998.
86. Boon, T., Coulie, P. G., and Van den Eynde, B., Tumor antigens recognized by T cells, Immunol., Today, 18, 267-272, 1997.
87. Cohen, E. P. and Kim, T. S., Neoplastic cells that express low levels of MHC class I determinants escape host immunity, Semin. Cancer Biol. 5, 419-428, 1994.
88. Cromme, F. V., Airey, J., Heemels, M. T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J., and Walboomers, J. M., Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas, J. Exp. Med., 179, 335-340, 1994.
89. Sadovnikova, E. and Stauss, H. J., Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy, Proc. Natl. Acad. Sci. U.S.A., 93, 13114-13118, 1996.
90. Vierboom, M. P. M., Nijman, H. W., Offringa, R., van der Voort, E. I. H., van Hall, T., van den Broek, L., Fleuren, G. J., Kenemans, P., Kast, W. M., and Melief, C. J. M., Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes, J. Exp. Med., 186, 695-704, 1997.
91. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E, J. Exp. Med., 176, 1453-1457, 1992.
92. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med., 178, 489-495, 1993.
93. Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A., Tumor antigens recognized by T lymphocytes, Annu. Rev. Immunol., 12, 337-365, 1994.
94. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, J. Exp. Med., 179, 921-930, 1994.
95. Ridgway, W. M., Weiner, H. L., and Fathman, C. G., Regulation of autoimmune response, Curr. Opin. Immunol., 6, 946-955, 1994.
96. Noguchi, Y., Richards, E. C., Chen, Y. T., and Old, L. J., Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma, Proc. Natl. Acad. Sci U.S.A., 92, 2219-2223, 1995.
97. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke M. R., Lotze M. T., and Storkus W. J., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines, J. Exp. Med., 183, 87-97, 1996.
98. + cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tumor helper peptides in priming for skin test reactivity to a P815AB-related peptide, Eur. J. Immunol., 25, 2797-2802, 1995.
99. Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Fienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., and Ohashi, P. S., Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy, J. Exp. Med., 186, 645-653, 1997.
100. Kilshaw, P. J., Brent, L., and Pinto, M., Suppressor T cells in mice made unresponsive to skin allografts, Nature, 255, 489-491, 1975.
101. Qin, S., Cobbold, S. P., Pope, H., Elliott, J., Kioussis, D., Davies, J., and Waldmann, H., "Infectious" transplantation tolerance, Science, 259, 974-976, 1993.
102. Yin, D. and Fathman, C. G., CD4-positive suppressor cells block allotransplant rejection, J. Immunol., 154, 6339-6345, 1995.
103. Lombardi, G., Sidhu, S., Batchelor, R., and Lechler, R., Anergic T cells as suppressor cells in vitro, Science, 266, 464-465, 1994.
104. Davies, J. D., Martin, G., Phillips, J., Marshall, S. E., Cobbold, S. P., and Waldmann, H., T-cell regulation in adult transplantation tolerance, J. Immunol., 157, 529-533, 1996.
105. Frasca, L., Carmichael, P., Lechler, R., and Lombardi, G., Anergic T cells affect linked suppression, Eur. J. Immunol., 27, 3191-3197, 1997.
106. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., and Weiner, H. L., Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis, Science, 265, 1237-1240, 1994.
107. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F., and Kosaka, H., Constitutive class I-restricted exogenous presentation of self antigens in vi J. Exp. Med., 184, 923-930, 1996.
108. + T-cell deletion induced by cross-presentation of self-antigens and favors autoimmunity, J. Exp. Med., 186(12), 2057-2062, 1997.
109. Kruisbeek, A. M. and Amsen, D., Mechanism underlying T-cell tolerance, Curr. Opin. Immunol., 8, 223-244, 1996.
110. + T cells leads to defective help for B-cell growth and differentiation, J. Immunol., 158, 4704-4713, 1997.
111. Heargraves, R. G., Borthwick, N. J., Gilardini Montani, M. S., Piccolella, E., Carmichael, P., Lechler, R. I., Akbar, A. N., and Lombardi, G., Dissociation of T-cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling, J. Immunol., 158, 3099-3107, 1997.
112. Bowen, F., Halusdey, J., and Quill, H., Altered CD40 ligand induction in tolerant T lymphocytes, Eur. J. Immunol., 25, 2830-2834, 1995.
113. Itoh, N., Yonehara, S., Ishii A., Yonahara, M., Mizushima, S. I., Sameshima, M., Hase, A., Seto, Y., and Nagata S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233-243, 1991.
114. Ohem, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trouth, P. C., Ponstingl, H., and Krammer, P. H., Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF-NGF-receptor superfamily, J. Biol. Chem, 267, 10709-10715, 1992.
115. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., and Nagata, S., The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen, J. Immunol., 148, 1274-1279, 1992.
116. Beutler, B. and van Huffel, C., Unraveling function in the TNF ligand and receptor families, Science, 264, 667-668, 1994.
117. Smith, C. A., Farrah, T., and Goodwin, R. G., The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death, Cell, 76, 959-962, 1994.
118. Suda, T., Takahashi, T., Golstein, P., and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169-1178, 1993.
119. Suda, T. and Nagata, S., Purification and characterization of the Fas-ligand that induces apoptosis, J. Exp. Med. 179, 873-879, 1994.
120. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediated apoptosis, Nature, 356, 314-317, 1992.
121. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S., and Taniguchi, N., Differential expression of apoptosis-related Fas antigen on lymphocytes subpopulation in human peripheral blood, J. Immunol., 149, 3753-3758, 1992.
122. Onel, K. B., Tucek-Szabo, C. L., Ashany, D., Lacy, E., Nikolic-Zugic, J., and Elkon, K. B., Expression and function of the murine CD95/FasR/APO-l receptor in relation to B cell ontogeny, Eur. J. Immunol., 25, 2940-2947, 1995.
123. Yonehara, S., Ishii, A., and Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp. Med., 169, 1747-1756, 1989.
124. Trauth, B. C., Klas, C., Peters, A. N., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer P. H., Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science 245, 301-304, 1989.
125. Owen-Schaub, L. B., Yonehara, S., Crump, W. L., III, and Grimm, E. A., DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement, Cell. Immunol., 140, 197-205, 1992.
126. Klas, C., Debatin, K. M., Jonker, R. R., and Krammer P. H., Activation interferes with the APO-1 pathway in mature human T cells, Int. Immunol., 5, 6625-6630, 1993.
127. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K., and Nagata, S., Expression of the Fas ligand in cells of T-cell lineage, J. Immunol., 154, 3806-3813, 1995.
128. Hahne, M., Renno, T., Schroeter, M., Irmler, M., French, L., Bornard, T., MacDonald, H. R., and Tschopp, J., Activated B cells express functional Fas ligand, Eur. J. Immunol., 26, 721-724, 1996.
129. Griffith, T. S., Brunner, T., Fletcher, S. M., Douglas, R. G., and Ferguson, T. A., Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189-1192, 1995.
130. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S., Lethal effect of the anti-Fas antibody in mice, Nature, 364, 806-809, 1993.
131. Russell, J. H., Rush, B., Weaver, C., and Wang, R., Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide, Proc. Natl. Acad. Sci. US.A., 90, 4409-4413, 1993.
132. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell, 76, 969-976, 1994.
133. Nagata, S. and Suda, T., Fas and Fas ligand: lpr and gld mutations, Immunol. Today, 16, 39-43, 1995.
134. Nagata, S. and Golstein, P., The Fas death factor, Science, 267, 1449-1456, 1995.
135. Watanabe, D., Suda, T., Hashimoto, H., and Nagata, S., Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders, EMBO J., 14, 12-18, 1995.
136. Russell, J. H., White, C. L., Loh, D. Y., and Meleedy-Rey, P., Receptor-stimulated death pathway is opened by antigen in mature T cells, Proc. Natl. Acad. Sci. U.S.A., 88, 2151-2155, 1991.
137. Kabelitz, D., Pohl, T., and Pechhold, K., Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes, Immunol. Today, 14, 338-339, 1993.
138. Lenardo, M. J., Fas and the art of lymphocyte maintenance, J. Exp. Med., 183, 721-724, 1996.
139. +T cells from HIV-gp120-induced apoptosis, Eur. J. Immunol., 25, 2917-2922, 1995.
140. Russell, J. H. and Wang, R., Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells, Eur. J. Immunol., 23, 2379-2382, 1993.
141. Alderson, M. R., Tough, T. W., Davis-Smith; T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes, J. Exp. Med., 181, 71-77, 1995.
142. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., and Krammer, P. H., Autocrine T-cell suicide mediated by Apo-l/(Fas/CD95), Nature, 373, 438-441, 1995.
143. Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A., Fas(CD95)/FasL interaction required for programed cell death after T-cell activation, Nature, 373, 444-448, 1995.
144. Vignaux, F., Vivier, E., Malissen, B., Depraetere, V., Nagata, S., and Golstein, P., TCR/CD3 coupling to Fas-based cytotoxicity, J. Exp. Med., 181, 781-786, 1995.
145. Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., Stricker, K., Baumler, C., Hellbardt, Germer, M., Peter, M. E., and Debatin, K.-M., The role of APO-1-mediated apoptosis in the immune system, Immunol. Rev., 142, 175-191, 1994.
146. Lynch, D. H., Ramsdell, F., and Alderson, M. R., Fas and FasL in the homeostatic regulation of immune responses, Immunol. Today, 16, 569-573, 1995.
147. Mogil, R. J., Radvanyi, L., Gonzalez-Quintial, R., Miller, R., Mills, G., Theofilopoulos A. N., and Green, D. R., Fas (CD95) participates in peripheral T-cell deletion and associated apoptosis in vivo, Int. Immunol., 7, 1451-1458, 1995.
148. Van Parijs, L. and Abbas, A. K., Role of fas-mediated cell death in the regulation of immune responses, Curr. Opin. Immunol., 8, 355-361, 1996.
149. + T cells in mice tolerant to staphylococcus aureus enterotoxin B, Nature, 349, 245-248, 1991.
150. D'Adamio, L., Awad, K. M., and Reinherz, E. L., Thymic and pheripheral apoptosis of antigen-specific T cells might cooperate in establishing self tolerance Eur. J. Immunol., 23, 747-753, 1993.
151. Scott, D. E., Kisch, W. J., and Steinberg, A. D., Studies of T-cell deletion and T-cell anergy following in vivo administration of SEB to normal and lupusprone mice, J. Immunol., 150, 664-672, 1993.
152. +Vß5 cells, J. Immunol., 152, 4270-4281, 1994.
153. + T cells responding to a bacterial superantigen, J. Immunol., 154, 4302-4308, 1995.
154. Rieux-Laucat, F., Le Diest, F., Hivroz, C., Roberts, I. A. G., Debatin, K.-M., Fischer, A., and de Villartay, J. P., Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science, 1995; 268:1347-1349.
155. + T cells, Nature, 376, 181-185, 1995.
156. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J, and Puck, J. K., Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell, 81, 935-946, 1995.
157. Bettinardi, A., Brugnoni, D., Quiròs-Roldan, E., Malagoli, A., La Grutta, S., Correra, A., and Notarangelo, L. D., Missense mutations in the fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis, Blood, 89, 902-909, 1997.
158. Swain, S. L., Dennert, G., Wormsley, S., and Dutton, R. W., The Lyt phenotype of a long-term allospecific T-cell line: both helper and killer activities to IA are mediated by Ly-1 cells, Eur. J. Immunol., 11, 175-180, 1981.
159. + T lymphocytes in culture, Nature, 308, 365-367, 1984.
160. Tite, J. P., Powell, M. B., and Ruddle, N. H., Protein-antigen specific
161. Chang, J. C. C. and Moorhead, J. W., Hapten-specific, class II-restricted killing by cloned T cells: direct lysis and production of a cytotoxic factor, J. Immunol., 136, 2826-2831, 1986.
162. Nakamura, M., Ross, D. T., Briner, T. J., and Gefter, M. L., Cytolytic activity of antigen-specific T cells with helper phenotype, J. Immunol., 136, 44-47, 1986.
163. Ozaki, S., York-Jolley, J., Kawamura, H., and Berzofsky, J. A., Cloned protein antigen-specific, Ia-restricted T cells with both helper and cytolytic activities: mechanisms of activation and killing, Cell. Immunol., 105, 301-316, 1987.
164. Braakman, E., Rotteveel, F. T. M., van Bleek, G., van Seventer, G. A., and Lucas, C. J., Are MHC class II-restricted cytotoxic T lymphocytes important?, Immunol. Today, 8, 265-267, 1987.
165. Lanzavecchia, A., Is suppression a function of class II-restricted cytotoxic T cells? Immunol. Today, 10, 157-159, 1989.
166. + T-cell-mediated killing of MHC class II-positive antigen-presenting cells, J. Immunol., 144, 790-795, 1990.
167. Tite, J. P., Differential requirement for protein synthesis in cytolisis mediated by class I and class II MHC-restricted cytotoxic T cells, Immunology, 70, 440-445, 1990.
168. Ju, S.-T., Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation, J. Immunol., 146, 812-818, 1991.
169. Lancki, D. W., Hsieh, C.-S., and Fitch, F. W., Mechanism of lysis by cytotoxic T lymphocyte clones, J. Immunol., 146, 3242-3249, 1991.
170. + cytotoxic T cells induce apoptosis of APC, Eur. J. Immunol., 22, 267-272, 1992.
171. Hahn, S., Gerhi, R., and Erb, P., Mechanism and biological significance of CD4-mediated cytotoxicity, Immunol. Rev., 146, 57-79, 1995.
172. 2+-independent T-cell-mediated cytotoxicity, J. Exp. Med., 177, 195-200, 1993.
173. Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraere, V., Nagata, S., Hengartner, H., and Golstein, P., Fas and perform pathways as major mechanisms of T-cell-mediated cytotoxicity, Science, 265, 528-530, 1994.
174. Lowin, B., Hahne, M., Mattmann, C., and Tschopp, J., Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature, 370, 650-652, 1994.
175. Walsh, D. M., Williams, C. H., Kennedy, H. E., Allsop, D., and Murphy, G., Gelatinase A not α-secretase?, Nature, 367, 27-28, 1994.
176. + T-cell-mediated cytotoxicity, J. Immunol., 1994; 152, 1127-1136, 1994.
177. 8+ cytotoxic T cells, Proc. Natl. Acad. Sci. U.S.A., 91, 4185-4189, 1994.
178. + T-cell-mediated cytotoxicity, J. Immunol., 152, 1127-1136, 1994.
179. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H., and Okumura, K., Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity, Proc. Natl. Acad. Sci. U.S.A., 91, 4930-4934, 1994.
180. Kägi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., and Hengartner, H., Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo, Annu. Rev. Immunol., 14, 207-232, 1996.
181. + cytotoxic T lymphocytes that lyse human monocytes, J. Exp. Med., 168, 1947-1952, 1988.
182. + cytotoxic T-cell clones, J. Exp. Med., 171, 2011-2024, 1990.
183. + cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 sub-unit vaccine, J. Infect. Dis., 168, 92-100, 1993.
184. + T-cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis, J. Immunol., 158, 2756-2761, 1997.
185. Vignaux, F. and Golstein, P., Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulaory pathway?, Eur. J. Immunol., 24, 923-927, 1994.
186. Ramsdell, F., Seaman, M. S., Miller, R. E., Picha, K. S., Kennedy, M. K., and Lynch, D. H., Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death, Int. Immunol., 6, 1545-1553, 1994.
187. + T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction, Eur. J. Immunol., 25, 2679-2685, 1995.
188. Burstein, H. J., Shea, C. M., and Abbas, A. K., Aqueous antigens induce in vivo tolerance selectively in IL-2 and IFN-γ producing (Th1) cells, J. Immunol., 148, 3687-3691, 1992.
189. De Wit, K., Van Mechelen, M., Eyelandt, M., Flgueiredo, A. C., Abramowicz, D., Goldman, M., Bazin, H., Urbain, J., and Lzo, O., The injection of deaggregated γ globulins in adult mice induces antigen-specific unresponsiveness of T helper type1 but not type 2 lymphocytes, J. Exp. Med., 175, 9-14, 1992.
190. + T cells from human immunodeficiency virus-infected persons, J. Exp. Med., 182, 1759-1767, 1995.
191. Zhang, X., Brunner, T., Carter, L., Dutton, R. W., Rogers, P., Bradley, L., Sato, T., Reed, J. C., Green, D., and Swain, S. L., Unequal death in T helper cell (Th1) and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis, J. Exp. Med., 185, 1837-1849, 1997.
192. Watanabe, N., Arase, H., Kurasawa, K., Iwamoto, I., Kayagaki, N., Yagita, H., Okumura, M., Miyatake, S., and Saito, T., Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death, Eur. J. Immunol., 27, 1858-1864, 1997.
193. + T cells in the pathogenesis of organ-specific autoimmune diseases, Immunol. Today, 16, 34-38, 1995.
194. Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., and Friedman, S. M., CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway, J. Exp. Med., 182, 1557-1565, 1995.
195. + T cells, Nature, 376, 181-185, 1995.
196. + T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells, Blood, 88, 1375-1382, 1996.
197. Rathmell, J. C., Townsend, S. E., Wu, J. C., Flavell, R. A., and Goodnow, C. C., Expansion of elimination of B cells in vivo: dual roles for CD40 and Fas (CD95)-ligands modulated by B cell antigen receptor, Cell 87, 319-329, 1996.
198. Eisenberg, R. A., Sobel, E. S., Reap, E. A., Halpern, M. D., and Cohen, P. L., The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice, Sem. Immunol., 6, 9-54, 1994.
199. Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., and Marshak-Rothstein, A., Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells, Nature, 374, 163-166, 1995.
200. L expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4, Mol. Immunol., 33, 1247-1253, 1996.
201. Puck, J. M. and Sneller, M., ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis, Sem. Immunol., 9, 77-84, 1997.
202. + T cells via Fas/Fas ligand-mediated apoptosis, J. Immunol., 158, 1503-1506, 1997.
203. Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S., and Nagai, K., Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fasbased lytic pathways in cell-mediated cytotoxicity, J. Immunol., 156, 3678-3686, 1996.
204. + CTL, J. Immunol., 159, 2728-2734, 1997.
205. + T helper 1 effectors, J. Immunol., 157, 2961-2968, 1996.
206. Sidhu, S., Deacock, S., Bal, V., Batchelor, J. R., Lombardi, G., and Lechler, R. I., Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells, J. Exp. Med., 176, 875-880, 1992.
207. Cossarizza, A., Ortolani, C., Mussini, C., Borghi, V., Guaraldi, G., Mongiardo, N., Bellesia, E., Franceschini, M. G., De Rienzo, B., and Franceschi, C., Massive activation of immune cells with an intact T-cell repertoire in acute human immunodeficiency virus syndrome, J. Infect. Dis., 172, 105-112, 1995.
208. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., and Fauci, A. S., HIV infection is active and progressive in lymphoid tissue during the clinical latent stage of disease, Nature, 362, 355-359, 1993.
209. Gehri, R., Hahn, S., Rothen, M., Steuerwald, M., Neusch, R., and Erb, P., The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells, AIDS, 10, 9-16, 1996.
210. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., and Methis, D., Mice lacking MHC class II molecules, Cell, 66, 1051-1066, 1991.
211. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsedell, F., and Lynch, D. H., Fas transduces activation signals in normal human T lymphocytes, J. Exp. Med., 178, 2231-2235, 1993.
212. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R., Two types of mouse T helper cell IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, J. Exp. Med. 170, 2081-2095, 1989.
213. Martinez, O. M., Gibbons, R. S., Garovoy, M. R., and Aronson, F. R., IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells, J. Immunol., 144, 2211-2215, 1990.
214. Davies, J. D., Martin, G., Phillips, J., Marshall, S. E., Cobbold, S. P., and Waldmann, H., T-cell regulation in adult transplantation tolerance, J. Immunol., 157, 529-533, 1996.
215. Marshall, S. E., Cobbold, S. P., Davies, J. D., Martin, G. M., Phillips, J. M., and Waldmann, H., Tolerance and suppression in a primed immune system, Transplantation, 62, 1614-1621, 1996.
216. + T-cell-mediated graft rejection, Eur. J. Immunol., 27, 1663-1670, 1997.
217. Go, C., Lancki, D. W., Fitch, F. W., and Miller, J., Anergized T-cell clones retain their cytolytic ability, J. Immunol., 150, 367-376, 1993.
218. Suda, T., Tanaka, M., Miwa, K., and Nagata, S., Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand, J. Immunol. 157, 3918-3924, 1996.
219. Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K.-M., and Krammer, P. H., Resistance of cultured peripheral T cells toward activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase8) to the CD95 death-inducing signaling complex, Eur. J. Immunol., 27, 1207-1212, 1997.
220. Boussiotis, V. A., Lee, B. J., Gordon, G. J., Freeman, J., Gribben, J. G., and Nadler, L. M., Induction of T-cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programed cell death, J. Immunol., 159, 3156-3167, 1997.
221. + T cells, Eur. J. Immunol., 27, 598-608, 1997.